These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 12560938

  • 1. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S, Chinello P, De Silvestro G, Marson P, Picco G, Varotto S, Pittalis S, Zanesco L.
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
    Rutella S, Pierelli L, Sica S, Serafini R, Chiusolo P, Paladini U, Leone F, Zini G, D'Onofrio G, Leone G, Piccirillo N.
    Cytotherapy; 2003 Feb; 5(1):19-30. PubMed ID: 12745586
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.
    Grigull L, Schrauder A, Schmitt-Thomssen A, Sykora K, Welte K.
    Infection; 2002 Oct; 30(5):267-71. PubMed ID: 12382084
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study.
    Kikuta A, Ohto H, Nemoto K, Mochizuki K, Sano H, Ito M, Suzuki H.
    Vox Sang; 2006 Jul; 91(1):70-6. PubMed ID: 16756604
    [Abstract] [Full Text] [Related]

  • 5. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions.
    Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V, Lang H, Lange W.
    Ann Hematol; 2002 May; 81(5):273-81. PubMed ID: 12029537
    [Abstract] [Full Text] [Related]

  • 6. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE.
    Cancer; 2006 Jun 15; 106(12):2664-71. PubMed ID: 16691620
    [Abstract] [Full Text] [Related]

  • 7. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I, Cepulić BG, Mazić S.
    Acta Med Croatica; 2009 Jun 15; 63(3):237-44. PubMed ID: 19827352
    [Abstract] [Full Text] [Related]

  • 8. The value and practicality of granulocyte transfusion: a single oncology centre experience.
    Al-Tanbal H, Al Humaidan H, Al-Nounou R, Roberts G, Tesfamichael K, Owaidah T.
    Transfus Med; 2010 Jun 15; 20(3):160-8. PubMed ID: 20070613
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte transfusions in the G-CSF era. Where do we stand?
    Robinson SP, Marks DI.
    Bone Marrow Transplant; 2004 Nov 15; 34(10):839-46. PubMed ID: 15273712
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ, Reiter A, Walter T, Bein G, Woessmann W.
    Transfusion; 2006 Nov 15; 46(11):1909-14. PubMed ID: 17076845
    [Abstract] [Full Text] [Related]

  • 11. Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions.
    Atay D, Ozturk G, Akcay A, Yanasik M, Anak S, Devecioglu O.
    J Pediatr Hematol Oncol; 2011 Aug 15; 33(6):e220-5. PubMed ID: 21792027
    [Abstract] [Full Text] [Related]

  • 12. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.
    Grigull L, Pulver N, Goudeva L, Sykora KW, Linderkamp C, Beilken A, Seidemann K, Schmid H, Welte K, Heuft HG.
    Support Care Cancer; 2006 Sep 15; 14(9):910-6. PubMed ID: 16622651
    [Abstract] [Full Text] [Related]

  • 13. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
    Heuft HG, Goudeva L, Pulver N, Grigull L, Schwella N, Blasczyk R.
    Transfusion; 2005 Apr 15; 45(4):604-12. PubMed ID: 15819683
    [Abstract] [Full Text] [Related]

  • 14. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK, Seipelt G, Langenhan S, Reutzel R, Schott D, Schoeffski O, Illiger HJ, Hartmann F, Balleisen L, Franke A, Fiedler F, Huber C, Rasche H, Bergmann L, Ganser A, Pott C, Pasold R, Rudolph C, Ottmann OG, Gökbuget N, Hoelzer D.
    Ann Hematol; 2002 Oct 15; 81(10):570-4. PubMed ID: 12424538
    [Abstract] [Full Text] [Related]

  • 15. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI.
    Bone Marrow Transplant; 2000 Jan 15; 25(1):85-9. PubMed ID: 10654020
    [Abstract] [Full Text] [Related]

  • 16. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K.
    Am J Hematol; 2003 Feb 15; 72(2):82-93. PubMed ID: 12555210
    [Abstract] [Full Text] [Related]

  • 17. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
    Catalano L, Fontana R, Scarpato N, Picardi M, Rocco S, Rotoli B.
    Haematologica; 1997 Feb 15; 82(1):71-2. PubMed ID: 9107088
    [Abstract] [Full Text] [Related]

  • 18. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, Augustin K, Vij R, Trinkaus K, Dipersio JF, Adkins D.
    Transfusion; 2006 Jan 15; 46(1):14-23. PubMed ID: 16398726
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 15; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience.
    Pham HP, Rogoza K, Stotler B, Duffy D, Parker-Jones S, Ginzburg Y, Bhatia M, Cairo M, Schwartz J.
    J Pediatr Hematol Oncol; 2012 Nov 15; 34(8):e332-6. PubMed ID: 22858567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.